Key result
Study comparing TAPSE/sPAP ratio and cardiovascular outcomes in T2DM versus healthy volunteers reports no results.
Why the study?
The TAPSE/sPAP ratio is an established risk factor for pulmonary hypertension and all-cause mortality, but comparisons of cardiovascular outcomes using this ratio between type 2 diabetes mellitus patients and healthy volunteers were needed.
Does the TAPSE/sPAP ratio differ between patients with type 2 diabetes mellitus and healthy volunteers?
Observational
Does the TAPSE/sPAP ratio differ between patients with type 2 diabetes mellitus and healthy volunteers?
Answers are grounded in this paper and cite their sources.
May inform risk stratification in type 2 diabetes; hypothesis-generating and requires prospective validation before practice change.
Objective: In the literature, the tricuspid annular plane systolic excursion/systolic pulmonary arterial pressure (TAPSE/sPAP) ratio <0.55 mm/ mmHg has been expressed as a predictive risk factor for pulmonary hypertension.In addition, the TAPSE/sPAP ratio ≤0.32 mm/mmHg has been reported as a predictive risk marker for all-cause mortality.In this study, we compared patients with type 2 diabetes mellitus (DM) with healthy volunteers in terms of cardiovascular outcomes with TAPSE/sPAP ratio.Amaç: Literatürde triküspit anüler düzlem sistolik ekskürsiyon/sistolik pulmoner arter basıncı (TAPSE/sPAB) oranının <0,55 mm/mmHg olması pulmoner hipertansiyon için prediktif bir risk faktörü olarak ifade edilmiştir.Ayrıca, TAPSE/sPAB oranının ≤0,32 mm/mmHg olması, tüm nedenlere bağlı ölümler için öngörücü bir risk belirteci olarak bildirilmiştir.Bu çalışmada, TAPSE/sPAB oranı ile tip 2 diabetes mellitus (DM) hastalarını sağlıklı gönüllülerle kardiyovasküler sonuçlar açısından karşılaştırdık.Yöntem ve Gereçler: Bu çalışmada diyabetik hastalar ile sağlıklı gönüllüler, transtorasik ekokardiyografi ile belirlenen TAPSE/sPAB oranı açısından karşılaştırıldı.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2023) conducted an observational in Type 2 diabetes mellitus. Type 2 diabetes mellitus vs. Healthy volunteers was evaluated on Cardiovascular outcomes. The abstract describes a study comparing TAPSE/sPAP ratio and cardiovascular outcomes between patients with type 2 diabetes mellitus and healthy volunteers, but reports no results.
Synapse has enriched 10 related papers. Consider them for comparative context: